H.C. Wainwright raises Vir Biotechnology target price to $22 from $20
VIR•H.C. Wainwright raised its target price for Vir Biotechnology to $22 from $20.
Related News
US SEC will not pursue charges against climate group, warns of disclosure obligations
XOM•
Nasdaq trade halt volatility trading pause at 11:00 am
NXAT•
Worldwide Healthcare Trust estimates Oct. 6 NAV at 391.94p per share, cum income
XLV•
Nasdaq pauses BBCI trading for volatility at 11:06 a.m.
BBCI•
NYSE halts trading with news pending; last price $22.64
FMS•